Drug Profile
Research programme: kynurenine pathway modulators - TES Pharma/Ecole Polytechnique Federale de Lausanne
Latest Information Update: 28 Aug 2019
Price :
$50
*
At a glance
- Originator Ecole Polytechnique Federale de Lausanne.; Tes Pharma
- Class Small molecules
- Mechanism of Action Kynurenine modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Metabolic disorders
Most Recent Events
- 28 Aug 2019 No recent reports of development identified for research development in Metabolic-disorders in Italy
- 28 Aug 2019 No recent reports of development identified for research development in Metabolic-disorders in Switzerland
- 02 Jul 2015 Early research in Metabolic disorders in Italy and Switzerland (unspecified route)